MYGN Competitors & Alternatives
Compare Myriad Genetics Inc with similar stocks in the same industry
Diagnostics & Research
MYGN
Main Stock$4.54
Tradestie Score
32
Market Cap
$719.23M
Revenue Growth
-0.1%
Analyst Upside
-24.8%
Top Competitors
39 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
GRAL
GRAIL, Inc. Common Stock
|
$143.26
|
$2.24B | - | 32 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$28.35
|
$2.22B | - | 50 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$188.67
|
$1.77B | - | 32 | Compare |
|
NEOG
Neogen Corp
|
$12.15
|
$1.26B | - | 42 | Compare |
|
OPK
Opko Health Inc.
|
$1.56
|
$1.23B | - | 41 | Compare |
|
NEO
NeoGenomics, Inc.
|
$18.47
|
$1.13B | - | 28 | Compare |
|
CDNA
CareDx, Inc.
|
$67.15
|
$798.40M | 31.8 | 29 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$21.48
|
$719.31M | - | 46 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$35.56
|
$667.77M | - | 47 | Compare |
|
PSNL
Personalis, Inc. Common Stock
|
$16.28
|
$612.76M | - | 51 | Compare |
More MYGN Analysis
Data updated: Oct 03, 2026 | Industry: Diagnostics & Research (SIC 2835)
39 stocks in this industry